432 related articles for article (PubMed ID: 16482870)
1. Olanzapine in Gilles de la Tourette syndrome: beyond tics.
Van den Eynde F; Naudts KH; De Saedeleer S; van Heeringen C; Audenaert K
Acta Neurol Belg; 2005 Dec; 105(4):206-11. PubMed ID: 16482870
[TBL] [Abstract][Full Text] [Related]
2. A controlled study of sensory tics in Gilles de 1a Tourette syndrome and obsessive-compulsive disorder using a structured interview.
Chee KY; Sachdev P
J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):188-92. PubMed ID: 9048721
[TBL] [Abstract][Full Text] [Related]
3. Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome.
Szejko N; Saramak K; Lombroso A; Müller-Vahl K
Neurol Neurochir Pol; 2022; 56(1):28-38. PubMed ID: 34708399
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a Gluten-Free Diet in the Gilles de la Tourette Syndrome: A Pilot Study.
Rodrigo L; Álvarez N; Fernández-Bustillo E; Salas-Puig J; Huerta M; Hernández-Lahoz C
Nutrients; 2018 May; 10(5):. PubMed ID: 29735930
[TBL] [Abstract][Full Text] [Related]
5. [Tics and Gilles de la Tourette syndrome].
Tijero-Merino B; Gómez-Esteban JC; Zarranz JJ
Rev Neurol; 2009 Jan; 48 Suppl 1():S17-20. PubMed ID: 19222010
[TBL] [Abstract][Full Text] [Related]
6. Gilles de la Tourette's syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without tics: which symptoms discriminate?
Cath DC; Spinhoven P; van Woerkom TC; van de Wetering BJ; Hoogduin CA; Landman AD; Roos RA; Rooijmans HG
J Nerv Ment Dis; 2001 Apr; 189(4):219-28. PubMed ID: 11339317
[TBL] [Abstract][Full Text] [Related]
7. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome.
Worbe Y; Gerardin E; Hartmann A; Valabrégue R; Chupin M; Tremblay L; Vidailhet M; Colliot O; Lehéricy S
Brain; 2010 Dec; 133(Pt 12):3649-60. PubMed ID: 20959309
[TBL] [Abstract][Full Text] [Related]
8. Premonitory Urges in Patients with Gilles de la Tourette Syndrome: An Italian Translation and a 7-Year Follow-up.
Gulisano M; Calì P; Palermo F; Robertson M; Rizzo R
J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):810-6. PubMed ID: 26288345
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
[TBL] [Abstract][Full Text] [Related]
10. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder.
Cath DC; Spinhoven P; Landman AD; van Kempen GM
J Psychopharmacol; 2001 Jun; 15(2):111-9. PubMed ID: 11448084
[TBL] [Abstract][Full Text] [Related]
11. Reinforcement learning and Gilles de la Tourette syndrome: dissociation of clinical phenotypes and pharmacological treatments.
Worbe Y; Palminteri S; Hartmann A; Vidailhet M; Lehéricy S; Pessiglione M
Arch Gen Psychiatry; 2011 Dec; 68(12):1257-66. PubMed ID: 22147843
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome--a pilot study.
Stephens RJ; Bassel C; Sandor P
J Child Adolesc Psychopharmacol; 2004; 14(2):255-66. PubMed ID: 15319022
[TBL] [Abstract][Full Text] [Related]
13. Tics and fits. The current status of Gilles de la Tourette syndrome and its relationship with epilepsy.
Rickards H
Seizure; 1995 Dec; 4(4):259-66. PubMed ID: 8719917
[TBL] [Abstract][Full Text] [Related]
14. Repetitive behaviors in Tourette's syndrome and OCD with and without tics: what are the differences?
Cath DC; Spinhoven P; Hoogduin CA; Landman AD; van Woerkom TC; van de Wetering BJ; Roos RA; Rooijmans HG
Psychiatry Res; 2001 Mar; 101(2):171-85. PubMed ID: 11286820
[TBL] [Abstract][Full Text] [Related]
15. Deep brain stimulation for Gilles de la Tourette syndrome in children and youth: a meta-analysis with individual participant data.
Coulombe MA; Elkaim LM; Alotaibi NM; Gorman DA; Weil AG; Fallah A; Kalia SK; Lipsman N; Lozano AM; Ibrahim GM
J Neurosurg Pediatr; 2018 Oct; 23(2):236-246. PubMed ID: 30497215
[TBL] [Abstract][Full Text] [Related]
16. [Multiple tics and Gilles de la Tourette syndrome].
Müller K
Monatsschr Kinderheilkd; 1991 Jun; 139(6):330-5. PubMed ID: 1680219
[TBL] [Abstract][Full Text] [Related]
17. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
[TBL] [Abstract][Full Text] [Related]
18. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
Kompoliti K; Goetz CG
Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
[TBL] [Abstract][Full Text] [Related]
19. Determinants of quality of life in children with Gilles de la Tourette syndrome.
Bernard BA; Stebbins GT; Siegel S; Schultz TM; Hays C; Morrissey MJ; Leurgans S; Goetz CG
Mov Disord; 2009 May; 24(7):1070-3. PubMed ID: 19306279
[TBL] [Abstract][Full Text] [Related]
20. Predictors during childhood of future health-related quality of life in adults with Gilles de la Tourette syndrome.
Cavanna AE; David K; Orth M; Robertson MM
Eur J Paediatr Neurol; 2012 Nov; 16(6):605-12. PubMed ID: 22381812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
